Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | 12-2023 | 09-2023 | |
| Operating Expenses | 3,795 | 0 | 1,222 | 4,028 | 3,637 |
| Operating Income | -3,795 | N/A | -1,222 | -4,028 | -3,637 |
| Other Income | 41 | 0 | -487 | 1,137 | 45 |
| Pre-tax Income | -3,754 | 0 | -1,709 | -2,891 | -3,592 |
| Net Income Continuous | -3,754 | N/A | -1,709 | -2,891 | -3,592 |
| Net Income | $-3,754 | $N/A | $-1,709 | $-2,891 | $-3,592 |
| EPS Basic Total Ops | -0.88 | N/A | -4.95 | -5.28 | -14.41 |
| EPS Basic Continuous Ops | -0.86 | N/A | -4.94 | -5.38 | -14.38 |
| EPS Diluted Total Ops | -0.88 | N/A | -4.95 | -5.28 | -14.41 |
| EPS Diluted Continuous Ops | -0.86 | N/A | -4.94 | -5.38 | -14.38 |
| EPS Diluted Before Non-Recurring Items | -0.88 | N/A | N/A | N/A | -31.68 |
| EBITDA(a) | $-3,788 | $N/A | $-986 | $-3,736 | $-3,399 |